The Neurology Minute® podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology® journals, Neurology Today®, Continuum®, and more.
Neurology trainees, educators and critical-appraisal readers get a concise history of clinical neurology publishing. The episode connects continuous digital publication and transparent reporting with the enduring need for clinically relevant questions, robust methodology and conclusions that follow from the data.
Neurology, paediatric and adolescent-health teams get a concise care-transition update for young adults with epilepsy. It frames transition as clinical preparation rather than simple referral, with patient expectations, emotional uncertainty, medication review, seizure history and adult-service readiness all included in the handover.
Neurology, geriatrics and service-improvement listeners get a short update on prior authorisation reform in Medicare Advantage. Electronic requests, transparency, decision timelines, expedited review, oversight and the clinical consequences of administrative delay are framed as patient-care issues.
Neurology, paediatric and critical-care teams get a compact terminology and treatment update. Functional dissociative seizure terminology, focal and tonic-clonic seizure therapeutics, Dravet syndrome, NORS immunotherapy, COMBAT NORS and smartwatch-based tonic-clonic seizure detection are kept distinct.
Neurology learners get a concise classification update after the practical definition of epilepsy is met. Seizure type, epilepsy type and aetiology are separated, with focal versus generalised onset, consciousness, observable manifestations and overlapping genetic or structural causes guiding treatment planning.
Neurology, human-factors and medical-education readers get a concise consultation-skills update on Parkinson disease diagnosis. It frames uncertainty about diagnosis, treatment effects and long-term expectations as routine, and shows how explicit or implicit uncertainty can be paired with emotional acknowledgement without undermining trust.
A neurology refresher for first seizure, recurrent seizures and transient loss of awareness. It separates unprovoked, reflex and acutely provoked seizures, then links epilepsy diagnosis to two unprovoked events, high recurrence risk after one event, EEG, imaging and clinical semiology.
Neurology, cardiology and nephrology readers get a concise amyloid-neuropathy red-flag update. Progressive neuropathy should trigger review for orthostatic hypotension, cardiomyopathy, proteinuria, weight loss, bruising, purpura, anasarca, gait decline and ankle weakness rather than limb symptoms alone.
Neurology and critical-appraisal readers get a concise myasthenia gravis testing update. Acetylcholine receptor and MuSK antibodies remain the core serological tests, while LRP4 IgG is uncommon and inconsistently detected, so suspected double-seronegative disease still needs clinical pattern recognition, electrophysiology and reconsideration of alternatives.
Stroke teams and critical-appraisal readers get a focused TAPIS trial update on early aspirin plus ticagrelor after intravenous thrombolysis. The episode keeps NIHSS 4–10 selection, 90-day modified Rankin 0–1 outcomes, symptomatic intracranial haemorrhage and protocol caution together.
.svg)